Shenzhen International Institute for Biomedical Research
发明人:
Minfeng Shu,Stephen Mallon,Ralph R. Weichselbaum,Bernard Roizman
申请号：
US16488101
公开号：
US20190381132A1
申请日:
2017.05.17
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed is a method for treatment of a tumor in a subject comprising administering to the subject a therapeutically effective amount of an ATF3 activator. Use of an ATF3 activator in the preparation of a pharmaceutical composition for treatment of a tumor in a subject is also disclosed.
